BARCLAYS PLC

Position in TXMD — TherapeuticsMD, Inc.

CIK 312069 LONDON, X0

Position in TXMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48

+$1 QoQ

Shares Held

-50.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 45 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. TXMD ranks #59 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,302,737	$165,474,680
2	NBIX	Neurocrine Biosciences Inc	324,807	$54,742,970
3	TEVA	Teva Pharmaceutical Industries Ltd	1,343,554	$45,519,608
4	UTHR	UNITED THERAPEUTICS Corp	72,010	$39,017,177
5	VTRS	Viatris Inc	2,437,004	$38,699,622
6	INDV	Indivior Pharmaceuticals, Inc.	907,024	$37,215,193
7	HIMS	Hims & Hers Health, Inc.	861,006	$29,851,076
8	ALKS	Alkermes plc.	219,935	$11,524,592

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48	22	-50.0%	Shares	Defined	2026-08-14
2025-09-30	$47	44	-30.2%	Shares	Sole	2026-03-31
2023-12-31	$141	63	-98.4%	Shares	Sole	2026-03-24
2022-06-30	$39,800	4,000	-94.5%	Shares	Sole	2022-08-12
2022-03-31	$27,695	72,883	-84.6%	Shares	Sole	2022-05-16
2021-12-31	$170,366	473,240	+192.1%	Shares	Sole	2022-02-14
2021-09-30	$119,882	162,003	-47.2%	Shares	Sole	2021-11-09
2021-03-31	$410,969	306,694	+262.4%	Shares	Sole	2021-05-13
2020-12-31	$102,409	84,636	-22.3%	Shares	Sole	2021-02-11
2020-09-30	$172,159	108,962	+2042.0%	Shares	Sole	2020-11-12
2020-06-30	$6,358	5,087	+7726.2%	Shares	Sole	2020-08-12
2020-03-31	$68	65	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.